Abstract
Although the issue of whether sickle cell trait (SCT) is clinically benign or a significant health concern has not yet been resolved, the potential health risk to affected individuals is of vital importance and represents a tremendous challenge in protecting, promoting, and improving the health of the approximately 300 million people worldwide and 3 million people in the U.S. who possess the trait. In response to a request by the Sickle Cell Disease Association of America, in December 2009, the CDC convened a meeting of partners, stakeholders, and experts to identify the gaps in public health, clinical health services, epidemiologic research, and community-based outreach strategies and to develop an agenda for future initiatives. Through facilitated discussion and presentations in four topic areas, participants discussed pertinent issues, synthesized clinical research findings, and developed a coherent framework for establishing an agenda for future initiatives. A primary outcome of the meeting was to provide the first step of an iterative process to move toward agreement regarding appropriate counseling, care, and, potentially, treatment of people with SCT.
| Original language | English |
|---|---|
| Journal | American Journal of Preventive Medicine |
| Volume | 41 |
| Issue number | 6 SUPPL.4 |
| DOIs | |
| State | Published - Dec 1 2011 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Epidemiology
Cite this
Public health implications of sickle cell trait : A report of the CDC meeting. / Grant, Althea M.; Parker, Christopher S.; Jordan, Lanetta B; Hulihan, Mary M.; Creary, Melissa S.; Lloyd-Puryear, Michele A.; Goldsmith, Jonathan C.; Atrash, Hani K.
In: American Journal of Preventive Medicine, Vol. 41, No. 6 SUPPL.4, 01.12.2011.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Public health implications of sickle cell trait
T2 - A report of the CDC meeting
AU - Grant, Althea M.
AU - Parker, Christopher S.
AU - Jordan, Lanetta B
AU - Hulihan, Mary M.
AU - Creary, Melissa S.
AU - Lloyd-Puryear, Michele A.
AU - Goldsmith, Jonathan C.
AU - Atrash, Hani K.
PY - 2011/12/1
Y1 - 2011/12/1
N2 - Although the issue of whether sickle cell trait (SCT) is clinically benign or a significant health concern has not yet been resolved, the potential health risk to affected individuals is of vital importance and represents a tremendous challenge in protecting, promoting, and improving the health of the approximately 300 million people worldwide and 3 million people in the U.S. who possess the trait. In response to a request by the Sickle Cell Disease Association of America, in December 2009, the CDC convened a meeting of partners, stakeholders, and experts to identify the gaps in public health, clinical health services, epidemiologic research, and community-based outreach strategies and to develop an agenda for future initiatives. Through facilitated discussion and presentations in four topic areas, participants discussed pertinent issues, synthesized clinical research findings, and developed a coherent framework for establishing an agenda for future initiatives. A primary outcome of the meeting was to provide the first step of an iterative process to move toward agreement regarding appropriate counseling, care, and, potentially, treatment of people with SCT.
AB - Although the issue of whether sickle cell trait (SCT) is clinically benign or a significant health concern has not yet been resolved, the potential health risk to affected individuals is of vital importance and represents a tremendous challenge in protecting, promoting, and improving the health of the approximately 300 million people worldwide and 3 million people in the U.S. who possess the trait. In response to a request by the Sickle Cell Disease Association of America, in December 2009, the CDC convened a meeting of partners, stakeholders, and experts to identify the gaps in public health, clinical health services, epidemiologic research, and community-based outreach strategies and to develop an agenda for future initiatives. Through facilitated discussion and presentations in four topic areas, participants discussed pertinent issues, synthesized clinical research findings, and developed a coherent framework for establishing an agenda for future initiatives. A primary outcome of the meeting was to provide the first step of an iterative process to move toward agreement regarding appropriate counseling, care, and, potentially, treatment of people with SCT.
UR - http://www.scopus.com/inward/record.url?scp=81355150248&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81355150248&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2011.09.012
DO - 10.1016/j.amepre.2011.09.012
M3 - Article
C2 - 22099370
AN - SCOPUS:81355150248
VL - 41
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
SN - 0749-3797
IS - 6 SUPPL.4
ER -